Genetic variants screening for solid tumors

SOLIDaccuTest™ is an excellent tool to explorer variants associated with solid tumors using a comprehensive method of next-generation sequencing (NGS). It reflects the latest research trends and is optimized for the medical purpose by selecting essential genes of solid tumors including lung, colon, breast, skin brain, gastric, ovarian cancers, etc.

Working Process

Specification

SOLIDaccuTest™
DNA RNA
Certification CE-IVD RUO
Target disease Lung, gastric, colon, breast/ovarian cancer and melanoma, etc.
Target Enrichment method Hybridization & capture method
Quantity 96 tests/kit (8 runs per kit, up to 12 samples per run)
Specimen FFPE tissue, biopsy
Tumor %: >20%
Target gene 84 genes 29 genes
Target size 270 kb 80 kb
Turn around time 3 days 3.5 days
Variants type SNV, INDEL, CNV* Fusion
NGS platform illumina MiSeq, MiSeq Dx / MiSeq Reagent kit, v3, 300cycles
Analysis solution NGeneAnalySys™ (CE)
*RUO, Research Use Only

Ordering information

Products Cat.no Quantity
RUO CE-IVD
SOLIDaccuTest™ DNA
& NGeneAnalySys

NGB131R-096

NGB131V-096

96 tests

NGB131R-048

NGB131V-048

48 tests

SOLIDaccuTest™ RNA
& NGeneAnalySys

NGB132R-096

On the Process

96 tests

NGB132R-048

48 tests